NL
WES amyotrophic lateral sclerosis, ALS
This test is available for the following conditions:
- Conditions > Neurological > Amyotrophic lateral sclerosis
Turnaround time
Regular: 2-3 months / Rapid: 15 working days
Method
- Whole exome sequencing (WES)
This test is inclusive panelwide CNV analysis. Upon request a genomewide CNV analysis can be performed. This panel contains 27 genes.
Panel version:
DG 3.6
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA
WES aritmogene cardiomyopathy ¹
This test is available for the following conditions:
- Conditions > Cardiovascular > Arrhythmogenic right ventricular cardiomyopathy (ARVD)
- Conditions > Cardiovascular > Cardiomyopathy (HCM/DCM)
Turnaround time
8 weeks
Method
- Whole exome sequencing (WES)
This test is inclusive panelwide CNV analysis. Upon request a genomewide CNV analysis can be performed. This panel contains 9 genes.
Panel version:
DG 3.6
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA
WES arrhythmia and cardiac conduction disorders ¹
This test is available for the following conditions:
- Conditions > Cardiovascular > Long QT syndrome
- Conditions > Cardiovascular > Short QT syndrome
- Conditions > Cardiovascular > Sick sinus syndrome
Turnaround time
8 weeks
Method
- Whole exome sequencing (WES)
This test is inclusive panelwide CNV analysis. Upon request a genomewide CNV analysis can be performed. This panel contains 26 genes.
Panel version:
DG 3.6
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA
WES ciliopathies
This test is available for the following conditions:
- Conditions > Intellectual Disability > Ciliopathies (WES)
- Conditions > Multiple congenital anomalies (MCA) > Ciliopathies (WES)
Turnaround time
Regular: 2-3 months / Rapid: 15 working days
Method
- Whole exome sequencing (WES)
This test is inclusive panelwide CNV analysis. Upon request a genomewide CNV analysis can be performed.This panel contains 184 genes.
Panel version:
DG 3.6
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA
WES congenital heartdisease ¹
This test is available for the following conditions:
- Conditions > Cardiovascular > Congenital heart disease
Turnaround time
Regular: 2-3 months / Rapid: 15 working days
Method
- Whole exome sequencing (WES)
This test is inclusive panelwide CNV analysis. Upon request a genomewide CNV analysis can be performed.This panel contains 85 genes.
Panel version:
DG 3.6
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA
WES craniofacial anomalies
This test is available for the following conditions:
- Conditions > Multiple congenital anomalies (MCA) > Craniofacial anomalies (WES)
Turnaround time
Regular: 2-3 months / Rapid: 15 working days
Method
- Whole exome sequencing (WES)
This test is inclusive panelwide CNV analysis. Upon request a genomewide CNV analysis can be performed. This panel contains 191 genes.
Panel version:
DG 3.6
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA
WES dilated cardiomyopathy ¹
This test is available for the following conditions:
- Conditions > Cardiovascular > Cardiomyopathy (HCM/DCM)
Turnaround time
8 weeks
Method
- Whole exome sequencing (WES)
This test is inclusive panelwide CNV analysis. Upon request a genomewide CNV analysis can be performed. This panel contains 21 genes.
Panel version:
DG 3.6
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA
WES Disorders/differences of sex development (DSD) / Primary adrenal insufficiency
This test is available for the following conditions:
- Conditions > Disorders in sex development > Disorders/differences of sex development (DSD) / Primary adrenal insufficiency (WES)
- Conditions > Endocrine > Disorders/differences of sex development (DSD) / Primary adrenal insufficiency (WES)
Turnaround time
Regular: 2-3 months / Rapid: 15 working days
Method
- Whole exome sequencing (WES)
This test is inclusive panelwide CNV analysis. Upon request a genomewide CNV analysis can be performed. This panel contains 161 genes.
There are mapping difficulties for the CYP21A2 gene in WES. To analyze variants in the CYP21A2 gene, a specific gene test is recommended.
The genes from the panels WES Hypogonadotropic hypogonadism and WES Premature Ovarian Insufficiency are included in this panel.
Panel version:
DG 3.6
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA
